Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Rapt Therapeutics (United States)
InstitutionResearch output, impact & collaborations
Rapt Therapeutics (United States) is a research organisation in South San Francisco, US. OpenAlex records 530 works and 74,805 citations for it. 614 researchers list it as their most recent affiliation.
530
Works
74,805
Citations
614
Researchers
68.8
Avg h-index
How has Rapt Therapeutics (United States)'s publication output changed over time?
ScholarIQpublication output · 1992–2019
Output grew100% over the shown period — from 1 works in 1992 to 2 in 2019.
1
1
1
2
2
1
2
2
19921999200120032006200920162019
Who are the most-cited researchers behind Rapt Therapeutics (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on Rapt Therapeutics (United States)?
ScholarIQmost cited works
Functional Characterization of the <i>S. cerevisiae</i> Genome by Gene Deletion and Parallel Analysis
Elizabeth A. Winzeler, Daniel Shoemaker, Anna Astromoff, Hong Liang, Keith M. Anderson, Bruno André, Rhonda Bangham, Rocío Benito, Jef D. Boeke, Howard Bussey, Angela Chu, Carla J. Connelly, Karen Davis, Fred S. Dietrich, Sally Dow, Mohamed El Bakkoury, Françoise Foury, Stephen Friend, Erik Gentalen, Guri Giaever, Johannes H. Hegemann, Ted Jones, Michael T. Laub, Hong Liao, Nicole Liebundguth, David J. Lockhart, Anca Lucau‐Danila, Marc Lussier, Nasiha M’Rabet, P Ménard, Michael Mittmann, Chai Pai, Corinne Rebischung, José Luis Revuelta, Linda Riles, Christopher J. Roberts, Petra Ross‐Macdonald, Bart Scherens, M Snyder, Sharon Sookhai-Mahadeo, Reginald Storms, Steeve Véronneau, Marleen Voet, Guido Volckaert, Teresa R. Ward, Robert Wysocki, Grace S. Yen, Kexin Yu, Katja Zimmermann, Peter Philippsen, Mark Johnston, Ronald W. Davis
Science. 19994,040 Citations
Generation of superoxide by purified brain nitric oxide synthase.
Sovitj Pou, Wanida S. Pou, David S. Bredt, Solomon H. Snyder, Gerald M. Rosen
S140251998. 1992754 CitationsOPEN ACCESS
Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer
John Welsh, Patrick P. Zarrinkar, Lisa M. Sapinoso, S Kern, Cynthia Behling, Bradley J. Monk, David J. Lockhart, Robert A. Burger, Garret M. Hampton
Proceedings of the National Academy of Sciences. 2001659 CitationsOPEN ACCESS
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
Dominique P. Germain, Derralynn Hughes, Kathy Nicholls, Daniel G. Bichet, Roberto Giugliani, William R. Wilcox, Claudio Feliciani, Suma P. Shankar, Fatih Süheyl Ezgü, Hernan Amartino, Drago Bratkovic, Ulla Feldt‐Rasmussen, Khan Nedd, Usama Sharaf El Din, Charles Marques Lourenço, Maryam Banikazemi, Joel Charrow, Majed Dasouki, David N. Finegold, Pilar Giraldo, Özlem Göker-Alpan, Nicola Longo, C. Ronald Scott, Roser Torrá, Ahmad Tuffaha, Ana Jovanović, Stephen Waldek, Seymour Packman, Elizabeth Ludington, Christopher Viereck, John Kirk, Julie Yu, Elfrida R. Benjamin, Franklin K. Johnson, David J. Lockhart, Nina Skuban, Jeff Castelli, Jay Barth, Carrolee Barlow, Raphael Schiffmann
New England Journal of Medicine. 2016560 CitationsOPEN ACCESS
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
Derralynn Hughes, Kathy Nicholls, Suma P. Shankar, Gere Sunder–Plassmann, David M. Koeller, Khan Nedd, Gerard Vockley, Takashi Hamazaki, Robin Lachmann, Toya Ohashi, Iacopo Olivotto, Norio Sakai, Patrick Deegan, David Dimmock, François Eyskens, Dominique P. Germain, Özlem Göker-Alpan, É. Hachulla, Ana Jovanović, Charles Marques Lourenço, Ichiei Narita, Mark Thomas, William R. Wilcox, Daniel G. Bichet, Raphael Schiffmann, Elizabeth Ludington, Christopher Viereck, John Kirk, Julie Yu, Franklin K. Johnson, Pol Boudes, Elfrida R. Benjamin, David J. Lockhart, Carrolee Barlow, Nina Skuban, Jeffrey P. Castelli, Jay Barth, Ulla Feldt‐Rasmussen
S112540174. 2016390 CitationsOPEN ACCESS
How much of the research on Rapt Therapeutics (United States) is open access?
ScholarIQopen access share
75%OPEN ACCESS
Gold
0%
Green
8%
Hybrid
33%
Bronze
33%
Closed
25%